XHE
State Street SPDR S&P Health Care Equipment ETF
SPDR S&P Health Care Equipment ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Health Care Equipment Select Industry Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 135.7 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Jan 26, 2011 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| STAAR SURGICAL CO | 2.6 % |
| GLAUKOS CORP | 2.0 % |
| MEDLINE INC-CL A | 1.9 % |
| BUTTERFLY NETWORK, INC. CLASS A | 1.9 % |
| TELEFLEX INC | 1.9 % |
| LEMAITRE VASCULAR INC | 1.9 % |
| GLOBUS MEDICAL INC - A | 1.8 % |
| CRYOLIFE INC | 1.8 % |
| MASIMO CORPORATION | 1.8 % |
| GE HEALTHCARE TECHNOLOGIES INC. | 1.8 % |
Constituent Breakdown
| Number of holdings | 64 |
| Herfindahl-Hirschman Index | 162 |
| Wgt avg mkt cap (mns) | $22,809 |
| Large cap (>$10bn) | 35.9% |
| Mid cap ($2-10bn) | 29.6% |
| Small cap (<$2bn) | 32.1% |
| Developed mkts. | 97.3% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 90.6 % |
 |
IRELAND | 3.5 % |
 |
BRITAIN | 3.2 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -11.3% | -4.8% | -5.7% | -5.8% | -8.1% | 6.3% | -- | 7.8% |
| Dividend Yield | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% | -- | 0.9% |
| Total Returns | -11.3% | -4.7% | -5.6% | -5.8% | -8.1% | 6.4% | -- | 8.6% | Ann. Volatility | 22.3% | 23.9% | 21.3% | 21.3% | 24.3% | 22.8% | -- | 21.2% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.92 | 53% |
| MSCI EAFE | 0.90 | 44% |
| MSCI Emg Mkts | 0.67 | 32% |
Liquidity Measures
| Avg. volume (000) | 36 |
| ADV traded (mns) | $3 |
| Turnover | 2.2% |
| Avg. Bid/Ask (% of price) | 0.23% |
Technical Indicators
| 30d moving avg. (EMA) | $81.38 |
| Relative strength (RSI) | 54 |
| MACD/Signal | 0.32/-0.61 |
| Bollinger Bands (Upper/Lower) | $84.31/$75.26 |
| Short interest (% of AUM) | 27.4% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XHE |
Expenses vs. XHE |
ALTAR Score™ vs. XHE |
|---|---|---|---|---|
| IHI | iShares U.S. Medical Devices ETF | 35.6% | +5 bp | +1.2% |
| MDEV | First Trust Indxx Medical Devices ETF | 35.3% | +35 bp | +1.5% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 30.8% | +33 bp | -1.4% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 26.6% | +5 bp | +3.3% |
| FXH | First Trust Health Care AlphaDEX Fund | 22.5% | +27 bp | +1.7% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 21.6% | -6 bp | -1.0% |
| HEAL | Global X HealthTech ETF | 20.8% | +15 bp | -4.5% |
| FMED | Fidelity Disruptive Medicine ETF | 17.6% | +15 bp | -5.1% |
| FDHT | Fidelity Digital Health ETF | 16.8% | +4 bp | -1.6% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 16.6% | +30 bp | -2.6% |
Risk and Returns: XHE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/24/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.8%
ALTAR SCORE™
21st
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,196 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. XHE's ALTAR Score™ is approximately -0.8 standard
deviations above the category average. This places XHE in the 21st percentile
among funds in the category.
Sell-Side Consensus
$107.45
PRICE TARGET
+30.6%
UPSIDE